I'm hoping that if the M2M results are stellar, the FDA will waive the interim requirement for the S2C and request to see the results now.
"Is this an unrealistic expectation...?
Mild-Moderate results are stellar. FDA grants emergency approval.
Severe-Critical results are equally strong. FDA grants full approval."
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
My comments are just my opinions and should NOT be taken as investment advice.